DOJ Probes Abbott's Sales, Marketing Of Depakote

Law360, New York (November 6, 2009, 3:40 PM EST) -- The U.S. Department of Justice is investigating the way Abbott Laboratories has sold and marketed the anti-seizure drug Depakote, the company said Friday.

In a financial report with the U.S. Securities and Exchange Commission, Abbott said the U.S. Attorney's Office for the Western District of Virginia was trying to determine whether the company's practices violated civil or criminal laws.

Abbott said investigators are looking at possible violations of the federal False Claims Act, the Federal Food, Drug and Cosmetic Act and the Anti-Kickback Statute in connection...
To view the full article, register now.